Clinical trial · Interventional
Exercise Study in Patients With Lung Cancer
Pilot Study to Establish an Exercise Intervention in Patients With Lung Cancer
NCT01581346CI-TRIAL-00006760POSITIVEcompletedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In the course of their disease patients with Non small cell lung cancer (NSCLC) often experience impaired psychological and physical functioning resulting in a reduced quality of life (QoL). The aim of the study is to explore the feasibility and the effects of an eight weeks combined muscle strength and endurance training on physical capacity and QoL.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- exercise intervention
- description
- Pts were instructed to train at least 5 times/ week in the inpatient setting. After discharge pts were instructed to train in a home-based setting at least 3 times/week for a period of 8 weeks.
- interventionNames
- Other: Exercise intervention
Primary outcomes (1)
- measure
- - number of patients who are adherent to the exercise intervention
- timeFrame
- 8 months
- description
- Adherence is defined as: completion of at least two training sessions per week during minimum six weeks out of eight weeks of the intervention.
Secondary outcomes (2)
- measure
- - effects of the exercise intervention on psychological symptoms (e.g. quality of life)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Male and female patients * histological confirmed diagnosis of Non small cell lung cancer (NSCLC) * current treatment: chemo-and/or radiotherapy * age \> 18y * Body Mass Index (BMI) \> 18 * written informed consent Exclusion Criteria: * acute infection * immobility \> 2 days * severe neurological impairment * severe cardiac impairment * severe pulmonal impairment * severe renal impairment * acute bleedings * alcohol-/drug-abuse
References
Publications (0)
Data not yet available
No reference posted for this study.